Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)
Public ClinicalTrials.gov record NCT03566693. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Continuous Glucose Monitoring (CGM) in Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to compare the glycemic and quality of life benefits of diabetes management using Dexcom G6 continuous glucose monitoring (CGM) or self-monitored blood glucose (SMBG) made by study participants and their primary care physicians. Decisions will be based on insights from real-time use and retrospective insights, determined during remote visits. Participants will have type 2 diabetes and be using basal insulin (with or without oral medications and/or Glucagon-Like-Peptide-1 (GLP-1) analogue) and have an elevated Hemoglobin A1C (HbA1c).
Study identification
- NCT ID
- NCT03566693
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 176 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 29, 2018
- Primary completion
- Jan 3, 2021
- Completion
- Jan 3, 2021
- Last update posted
- Apr 20, 2021
2018 – 2021
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Keck School of Medicine @ USC | Los Angeles | California | 90022 | — |
| Scripps Whittier Diabetes Institute | San Diego | California | 92121 | — |
| Emory University | Atlanta | Georgia | 30303 | — |
| Northwestern Memorial | Chicago | Illinois | 60611 | — |
| Iowa Diabetes and Endocrinology Research Center | West Des Moines | Iowa | 50265 | — |
| University of Michigan Internal Medicine | Ann Arbor | Michigan | 48105 | — |
| Henry Ford Medical Center | Detroit | Michigan | 48202 | — |
| Park Nicollet International Diabetes Center | Minneapolis | Minnesota | 55416 | — |
| Washington University Barnes Jewish Hospital | St Louis | Missouri | 63130 | — |
| Las Vegas Endocrinology | Henderson | Nevada | 89052 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27517 | — |
| Carteret Medical Group | Morehead City | North Carolina | 28557 | — |
| Lucas Research / Diabetes & Endocrinology Consultants, PC | Morehead City | North Carolina | 28557 | — |
| Vanderbilt Eskind Diabetes Clinic | Nashville | Tennessee | 37212 | — |
| Amarillo Medical Specialists, LLP | Amarillo | Texas | 79106 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03566693, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2021 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03566693 live on ClinicalTrials.gov.